摘要
Journal of Labelled Compounds and RadiopharmaceuticalsVolume 44, Issue S1 p. S90-S92 Article 177Lu-DOTA-HuJ591: A new radiolabeled monoclonal antibody (MAb) for targeted therapy of prostate cancer P. M. Smith-Jones, P. M. Smith-Jones Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS Vallabhajosula, S Vallabhajosula Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS. St. Omer, S. St. Omer Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorV Navarro, V Navarro New York Presbyterian Hospital — Weill Medical College of Cornell University, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS. J. Goldsmith, S. J. Goldsmith Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorN. H. Bander, N. H. Bander New York Presbyterian Hospital — Weill Medical College of Cornell University, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this author P. M. Smith-Jones, P. M. Smith-Jones Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS Vallabhajosula, S Vallabhajosula Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS. St. Omer, S. St. Omer Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorV Navarro, V Navarro New York Presbyterian Hospital — Weill Medical College of Cornell University, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorS. J. Goldsmith, S. J. Goldsmith Division of Nuclear Medicine, Department of Radiology and Department of Urology, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this authorN. H. Bander, N. H. Bander New York Presbyterian Hospital — Weill Medical College of Cornell University, 525 East 68th Street, ST-221, New York, NY 10021Search for more papers by this author First published: 23 April 2012 https://doi.org/10.1002/jlcr.2580440131Citations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Israeli, R. S. et al. Cancer. Res. 54: 1807 (1994) CASPubMedWeb of Science®Google Scholar 2 Deb, N. et al. Clin. Cancer. Res. 2: 1289 (1996) CASPubMedWeb of Science®Google Scholar 3 Lui, H. et al. Cancer. Res. 57: 3629 (1997) PubMedWeb of Science®Google Scholar 4 Smith-Jones, P. M. et al. Cancer. Res. 60: 5237 (2000) CASPubMedWeb of Science®Google Scholar 5 Smith-Jones, P. M. et al. Eur. J. Nucl. Med. 8: 951 (2000) Google Scholar 6 Schlom, J. et al. Cancer. Res. 51: 2889 (1991) CASPubMedWeb of Science®Google Scholar 7 Lindmo, T. et al. Immunol. Method. 72: 77 (1984) 10.1016/0022-1759(84)90435-6 CASPubMedWeb of Science®Google Scholar Citing Literature Volume44, IssueS1Supplement: Journal of Labelled Compounds and RadiopharmaceuticalsMay 2001Pages S90-S92 ReferencesRelatedInformation